早期妊娠期糖尿病的检测与治疗:随机对照试验的系统综述与Meta分析
该系统综述与Meta分析纳入7篇随机对照试验共30791名参与者,评估早期妊娠期糖尿病检测与治疗对母婴结局的影响。研究发现治疗与常规护理相比仅次要结局有差异,人群筛查策略可提高早期及总体妊娠期糖尿病检出率并降低初次剖宫产率,但多数结局证据质量低或极低。
要点
- 治疗与常规护理相比,仅次要结局有差异:更多药物治疗、更少孕妇体重增加、更低出生体重和更少呼吸窘迫。
- 人群筛查策略与不筛查相比,早期妊娠期糖尿病风险比为5.50(95%CI 3.56-8.48),总体妊娠期糖尿病风险比为1.83(95%CI 1.41-2.38)。
- 人群筛查策略与不筛查相比,初次剖宫产风险比为0.88(95%CI 0.84-0.93),但妊娠期高血压和子痫前期风险更高。
核心结论
- 早期妊娠期糖尿病的检测与治疗对治疗女性或人群水平均未提供无可争议的获益,需要更多研究来阐明这一问题。
研究设计与样本
- 系统综述与Meta分析,检索Ovid Medline、Cochrane CENTRAL和Embase自建库至2024年11月,纳入7篇随机对照试验共30791名参与者,使用Cochrane手册和Risk of Bias 2工具评估偏倚风险,采用随机效应模型计算汇总相对风险和均数差及其95%置信区间,并使用GRADE标准总结主要结局证据质量。
主要发现
- 在治疗与常规护理比较的研究中,差异仅见于次要结局:更多药物治疗、更少孕妇体重增加、更低出生体重和更少呼吸窘迫。
- 在比较不同人群策略的研究中,主要结局差异为早期妊娠期糖尿病发生率更高(相对风险5.50,95%CI 3.56-8.48)和总体妊娠期糖尿病发生率更高(相对风险1.83,95%CI 1.41-2.38),以及初次剖宫产率更低(相对风险0.88,95%CI 0.84-0.93)。
- 次要结局方面,观察到妊娠期高血压和子痫前期发生率更高。
- 大多数结局的证据质量低或极低。
临床怎么用
- 原文未据此给出推荐。
局限性
- 大多数结局的证据质量低或极低。
- 需要更多研究来阐明早期妊娠期糖尿病检测与治疗的问题。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To estimate the impact of detection and treatment of early gestational diabetes mellitus on short-term maternal, fetal, and neonatal outcomes. We defined 2 maternal (gestational diabetes prevalence and cesarean section) and 2 neonatal (preterm birth and macrosomia) primary outcomes. We also defined 5 maternal and 12 fetal-neonatal secondary outcomes. DATA SOURCES: Ovid Medline, Cochrane CENTRAL, and Embase since inception. The search was updated in November 2024. STUDY ELIGIBILITY CRITERIA: Inclusion criteria: randomized controlled trials addressing detection and treatment of early gestational diabetes (diagnosed before 20 completed weeks). EXCLUSION CRITERIA: pregestational diabetes or overt diabetes in pregnancy. STUDY APPRAISAL AND SYNTHESIS METHODS: The Cochrane Handbook was used to guide data extraction and interpretation including risk of bias assessment (Risk of Bias 2 tool). Aggregation and comparison of results were performed with Revman 5.4.1. Pooled relative risk and mean differences were calculated with 95% confidence intervals using random-effects models. The quality of the evidence for primary outcomes was summarized using Grading of Recommendations Assessment, Development and Evaluation criteria. RESULTS: We identified 1221 unique references. Seven articles addressing early gestational diabetes met the eligibility criteria with a total of 30,791 participants. These studies used 2 strategies: (1) treatment vs usual care of women with a diagnosis of early gestational diabetes and (2) population-based approaches, either performing screening (vs not) or using different cutoffs for diagnosis. In studies comparing treatment vs usual care, differences were observed only in secondary outcomes: more drug treatment, less maternal weight gain, lower birthweight, and less respiratory distress. In studies comparing different population-based strategies, primary outcomes differed for a higher rate of early and overall gestational diabetes (relative risk, 5.50; 95% confidence interval, 3.56-8.48 and 1.83; 95% confidence interval, 1.41-2.38, respectively) and a lower rate of primary cesarean section (relative risk, 0.88; 95% confidence interval, 0.84-0.93); as to secondary outcomes, differences were observed in terms of higher total pregnancy-induced hypertension and preeclampsia. The quality of evidence for most outcomes was low/very low. CONCLUSION: Detection and treatment of early gestational diabetes mellitus do not offer indisputable benefits either in treated women or at the population level. More studies are required to elucidate this issue.
引用
- García-Patterson A, Balsells M, Solà I, et al. Detection and treatment of early gestational diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. Am J Obstet Gynecol. 2025. PMID: 40320104. doi:10.1016/j.ajog.2025.04.059
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。